TY - JOUR
T1 - Assessment of the quality of life (QoL) of patients with dermatitis and the impact of patch testing on QoL
T2 - A study of 519 patients diagnosed with dermatitis
AU - Boonchai, Waranya
AU - Charoenpipatsin, Norramon
AU - Winayanuwattikun, Waranaree
AU - Phaitoonwattanakij, Sutasinee
AU - Sukakul, Thanisorn
PY - 2020/9
Y1 - 2020/9
N2 - Background: Dermatitis can impair the quality of life (QoL) of patients. Knowledge of the QoL-associated factors and the impact of patch testing on QoL is limited. Objectives: To identify demographic and clinical factors affecting QoL, and to measure the impact of patch testing on QoL of dermatitis patients. Methods: The data and Dermatology Life Quality Index (DLQI) questionnaires of 519 dermatitis patients were analyzed. Of these, 107 underwent patch testing and completed the questionnaires two times (once before testing and again 60 days afterward). Results: The overall mean (±standard deviation) DLQI was 9.5 (±6.4). Patients aged 20 to 59 years and those who had more frequent disease exacerbations demonstrated significantly higher DLQIs. For each DLQI question, being female and aged 20 to 59 years were associated with impairments of various aspects of life, whereas the anatomical site of dermatitis impacted each question differently. The DLQI scores of the patients undergoing patch testing decreased significantly, irrespective of whether the test results were positive or negative. Conclusions: Being of a working age and having more frequent disease exacerbations had negative QoL impacts. In addition, patch testing improved almost every aspect of the DLQI.
AB - Background: Dermatitis can impair the quality of life (QoL) of patients. Knowledge of the QoL-associated factors and the impact of patch testing on QoL is limited. Objectives: To identify demographic and clinical factors affecting QoL, and to measure the impact of patch testing on QoL of dermatitis patients. Methods: The data and Dermatology Life Quality Index (DLQI) questionnaires of 519 dermatitis patients were analyzed. Of these, 107 underwent patch testing and completed the questionnaires two times (once before testing and again 60 days afterward). Results: The overall mean (±standard deviation) DLQI was 9.5 (±6.4). Patients aged 20 to 59 years and those who had more frequent disease exacerbations demonstrated significantly higher DLQIs. For each DLQI question, being female and aged 20 to 59 years were associated with impairments of various aspects of life, whereas the anatomical site of dermatitis impacted each question differently. The DLQI scores of the patients undergoing patch testing decreased significantly, irrespective of whether the test results were positive or negative. Conclusions: Being of a working age and having more frequent disease exacerbations had negative QoL impacts. In addition, patch testing improved almost every aspect of the DLQI.
KW - allergic contact dermatitis
KW - Dermatology Life Quality Index
KW - eczema
KW - facial dermatitis
KW - generalized dermatitis
KW - global assessment
KW - hand dermatitis
KW - patch test
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=85083673322&partnerID=8YFLogxK
U2 - 10.1111/cod.13535
DO - 10.1111/cod.13535
M3 - Article
C2 - 32212154
AN - SCOPUS:85083673322
SN - 0105-1873
VL - 83
SP - 182
EP - 188
JO - Contact Dermatitis
JF - Contact Dermatitis
IS - 3
ER -